Citation Impact
Citing Papers
Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54
2003 Standout
Hypogonadism and Obesity
1984
A Direct Effect of Hyperinsulinemia on Serum Sex Hormone-Binding Globulin Levels in Obese Women with the Polycystic Ovary Syndrome*
1991
The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
2004 Standout
Thiazolidinediones
2004 Standout
Hyperfunction of the Hypothalamic-Pituitary Axis in Women with Polycystic Ovarian Disease: Indirect Evidence for Partial Gonadotroph Desensitization*
1988
Clinical and Hormonal Effects of Chronic Gonadotropin Releasing Hormone Agonist Treatment in Polycystic Ovarian Disease*
1987
Physiological effects of inverse agonists in transgenic mice with myocardial overexpression of the β2-adrenoceptor
1995 StandoutNatureNobel
Long-Term Follow-Up of Spontaneous Development in a Boy with Familial Male Precocious Puberty
2004
Acanthosis Nigricans, Insulin Action, and Hyperandrogenism: Clinical, Histological, and Biochemical Findings*
1991
The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women
1995 Standout
Childhood obesity: public-health crisis, common sense cure
2002 Standout
Parkinson's disease: clinical features and diagnosis
2008 Standout
Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study1
1998 Standout
A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty
1993 Nature
Inhibition of Sex Hormone-Binding Globulin Production in the Human Hepatoma (Hep G2) Cell Line by Insulin and Prolactin*
1988
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
MEDICAL TREATMENT OF PROLACTINOMAS
1999
Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline
2011 Standout
Adrenergic receptor signal transduction and regulation
1995 StandoutNobel
Polycystic Ovary Syndrome
1995 Standout
The Ectodomain of the Luteinizing Hormone Receptor Interacts with Exoloop 2 to Constrain the Transmembrane Region
2002 StandoutNobel
The Third Intracellular Loop and the Carboxyl Terminus of β2-Adrenergic Receptor Confer Spontaneous Activity of the Receptor
2003 StandoutNobel
Monogenic Disorders of Puberty
2002
Polycystic Ovary Syndrome
2005 Standout
Estrogen Resistance Caused by a Mutation in the Estrogen-Receptor Gene in a Man
1994 Standout
Suppression of serum insulin level by diazoxide does not alter serum testosterone or sex hormone-binding globulin levels in healthy, nonobese women
1990
Medication-Induced Hyperprolactinemia
2005
Activation of the Luteinizing Hormone Receptor Following Substitution of Ser-277 with Selective Hydrophobic Residues in the Ectodomain Hinge Region
2000 StandoutNobel
Postmenopausal Estrogen Therapy and Cardiovascular Disease
1991 Standout
Polycystic ovary syndrome
1997
Seven transmembrane receptors—A brief personal retrospective
2006 StandoutNobel
Use of recombinant human chorionic gonadotropin in ovulation induction
2003
An Abnormality of the Growth Hormone/Insulin-Like Growth Factor-I Axis in Women with Polycystic Ovary Syndrome*
1990
Prevalence and Predictors of Risk for Type 2 Diabetes Mellitus and Impaired Glucose Tolerance in Polycystic Ovary Syndrome: A Prospective, Controlled Study in 254 Affected Women1
1999 Standout
Treatment of Familial Male Precocious Puberty with Spironolactone and Testolactone
1989
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Protein therapeutics: a summary and pharmacological classification
2007 Standout
The diagnosis of polycystic ovaries in women with oligo‐amenorrhoea: predictive power of endocrine tests
1991
Transmembrane Regions V and VI of the Human Luteinizing Hormone Receptor Are Required for Constitutive Activation by a Mutation in the Third Intracellular Loop
1996 StandoutNobel
Does transient hyperprolactinemia during ovarian hyperstimulation interfere with conception or pregnancy outcome?
1989
Structural Instability of a Constitutively Active G Protein-coupled Receptor
1997 StandoutNobel
Epidemiology of Obstructive Sleep Apnea
2002 Standout
Somatostatin analogs which inhibit glucagon and growth hormone more than insulin release
1977 StandoutNobel
Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis.
1992 StandoutNobel
Involutional Osteoporosis
1986 Standout
Effect of body weight reduction on plasma androgens in obese, infertile women
1982
Biologic Effects of Transdermal Estradiol
1986
Characterization of Groups of Hyperaiidrogenic Women with Acanthosis Nigricans, Impaired Glucose Tolerance, and/or Hyperinsulinemia*
1987 Standout
Perimenopause: The Complex Endocrinology of the Menopausal Transition
1998
Determinants of Bone Loss from the Femoral Neck in Women of Different Ages
2000
Health Consequences of Obesity in Youth: Childhood Predictors of Adult Disease
1998 Standout
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Endocrine and Paracrine Regulation of Birth at Term and Preterm*
2000 Standout
Polycystic ovarian disease
1981
Prolactin (PRL) and Its Receptor: Actions, Signal Transduction Pathways and Phenotypes Observed in PRL Receptor Knockout Mice
1998 Standout
Vitamin D Deficiency and Secondary Hyperparathyroidism in the Elderly: Consequences for Bone Loss and Fractures and Therapeutic Implications
2001 Standout
Inhibition by six somatostatin analogs of plasma growth hormone levels stimulated by thiamylal and morphine in the rat
1976 StandoutNobel
Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.
1976
10 Paracrine control of the testis
1986
Evidence for immunoreactive neurotensin in dog intestinal mucosa
1976 StandoutNobel
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis*
1997 Standout
Comparative Effects of Cyproterone Acetate or a Long-Acting Gonadotropin-Releasing Hormone Agonist in Polycystic Ovarian Disease
1986
Advances in the Treatment of Prolactinomas
2006
Potent prolactin and growth hormone releasing activity of more analogues of Met-enkephalin
1977 StandoutNatureNobel
Cerebrospinal Fluid and Plasma Vasopressin in the Fetal Lamb: Basal Concentration and the Effect of Hypoxia*
1985
Testosterone inhibits early atherogenesis by conversion to estradiol: Critical role of aromatase
2001
Long-Term Treatment of Prolactin-Secreting Macroadenomas with Pergolide
2000
Genetic heterogeneity of constitutively activating mutations of the human luteinizing hormone receptor in familial male-limited precocious puberty.
1995
Comparison of the effect of somatostatin on gastrointestinal function in the conscious and anaesthetized cat and on the isolated cat pancreas.
1977 StandoutNobel
Multiple receptors for dopamine
1979 StandoutNature
A Prospective Study of the Prevalence of the Polycystic Ovary Syndrome in Unselected Caucasian Women from Spain1
2000 Standout
Statins for women with polycystic ovary syndrome not actively trying to conceive
2011
Is caffeine consumption a risk factor for osteoporosis?
1992
Steroid Secretion in Polycystic Ovarian Disease after Ovarian Suppression by a Long-Acting Gonadotropin-Releasing Hormone Agonist*
1983
REVIEW ARTICLE: THE POLYCYSTIC OVARY SYNDROME
1980
Serum androgens and estrogens in postmenopausal women with and without endometrial cancer
1980
Estrogen replacement therapy by transdermal estradiol administration
1983
Somatostatin: Physiological and Clinical Significance
1976 StandoutNobel
Risk Factors for Hip Fracture in White Women
1995 Standout
Sertoli-Sertoli and Sertoli-Germ Cell Interactions and Their Significance in Germ Cell Movement in the Seminiferous Epithelium during Spermatogenesis
2004 Standout
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
Insulin Resistance in Nonobese Patients with Polycystic Ovarian Disease*
1983
The Oxytocin Receptor System: Structure, Function, and Regulation
2001 Standout
Hirsutism: Implications, etiology, and management
1981
Long-Term Treatment of Prolactin-Secreting Macroadenomas with Pergolide
2000
Actions of neurohypophysial peptides on pancreatic hormone release
1984
Ligand-induced overexpression of a constitutively active β 2 -adrenergic receptor: Pharmacological creation of a phenotype in transgenic mice
1997 StandoutNobel
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Prolactin
1977
STRUCTURE ACTIVITY STUDIES ON SOMATOSTATIN
1976
Evidence for the Importance of Peripheral Tissue Events in the Development of Hirsutism in Polycystic Ovary Syndrome*
1983
Immuno-fluorescent reactivity to anti-somatostatin in the gastro-intestinal mucosa of the dog
1975
Persistence of insulin resistance in polycystic ovarian disease after inhibition of ovarian steroid secretion
1986
Mutations of Gonadotropins and Gonadotropin Receptors: Elucidating the Physiology and Pathophysiology of Pituitary-Gonadal Function
2000
A sporadic case of male-limited precocious puberty has the same constitutively activating point mutation in luteinizing hormone/choriogonadotropin receptor gene as familial cases.
1994
Relationship between Circulating Estrogens and the Central Mechanisms by which Ovarian Steroids Stimulate Luteinizing Hormone Secretion in Aged and Young Female Rats*
1981
Hyperprolactinemia: Evaluation and Management
1992
Effects of Somatostatin on Plasma Glucose and Glucagon Levels in Human Diabetes Mellitus
1974 StandoutNobel
A new constitutively activating point mutation in the luteinizing hormone/choriogonadotropin receptor gene in cases of male-limited precocious puberty.
1995
TEMPORAL PATTERN FORMATION BY HETEROCHRONIC GENES
1997 StandoutNobel
Works of Gary W. DeVane being referenced
Ovarian-pituitary hormone interactions during the perimenopause
1989
Recombinant human chorionic gonadotropin (rhCG) in assisted reproductive technology: results of a clinical trial comparing two doses of rhCG (OvidrelR) to urinary hCG (ProfasiR) for induction of final follicular maturation in in vitro fertilization–embryo transfer
2001
Effects of Exogenous Estrogen and Progestin on Pituitary Responsiveness to Synthetic Luteinizing Hormone-Releasing Factor
1974
Effects of oral contraceptive steroids on pituitary prolactin secretion
1976
Circulating gonadotropins, estrogens, and androgens in polycystic ovarian disease
1975
An Apparent Stress-Induced Release of Arginine Vasopressin by Human Neonates*
1980
Bromocriptine therapy in normoprolactinemic women with unexplained infertility and galactorrhea
1986
ACUTE SUPPRESSION OF INSULIN AND GLUCOSE LEVELS BY SYNTHETIC SOMATOSTATIN IN NORMAL HUMAN SUBJECTS1
1974
Maternal Virilization Developing during a Twin Pregnancy
1973
Bromocriptine therapy in normoprolactinemic women with unexplained infertility and galactorrhea.
1986
Testicular Leydig Cell Hyperplasia as a Cause of Familial Sexual Precocity*
1981
Comparison of dopamine agonists in the treatment of hyperprolactinemic syndromes: a multicenter study
1983